Growing community of inventors

Odense, Denmark

Klaus Baek Simonsen

Average Co-Inventor Count = 4.57

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 28

Klaus Baek SimonsenKarsten Juhl (5 patents)Klaus Baek SimonsenNikolay Khanzhin (4 patents)Klaus Baek SimonsenSoren Moller Nielsen (4 patents)Klaus Baek SimonsenKarsten Juhl (2 patents)Klaus Baek SimonsenJan Kehler (1 patent)Klaus Baek SimonsenLars Kyhn Rasmussen (1 patent)Klaus Baek SimonsenYazhou Wang (1 patent)Klaus Baek SimonsenKate Wen (1 patent)Klaus Baek SimonsenNiels Svenstrup (1 patent)Klaus Baek SimonsenMorten Langgard (1 patent)Klaus Baek SimonsenNiels Svenstrup (1 patent)Klaus Baek SimonsenNikolay Khanzhin (1 patent)Klaus Baek SimonsenKate Wen (1 patent)Klaus Baek SimonsenYazhou Wang (1 patent)Klaus Baek SimonsenKlaus Baek Simonsen (5 patents)Karsten JuhlKarsten Juhl (53 patents)Nikolay KhanzhinNikolay Khanzhin (27 patents)Soren Moller NielsenSoren Moller Nielsen (4 patents)Karsten JuhlKarsten Juhl (5 patents)Jan KehlerJan Kehler (65 patents)Lars Kyhn RasmussenLars Kyhn Rasmussen (43 patents)Yazhou WangYazhou Wang (13 patents)Kate WenKate Wen (10 patents)Niels SvenstrupNiels Svenstrup (9 patents)Morten LanggardMorten Langgard (4 patents)Niels SvenstrupNiels Svenstrup (5 patents)Nikolay KhanzhinNikolay Khanzhin (2 patents)Kate WenKate Wen (1 patent)Yazhou WangYazhou Wang (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. H. Lundbeck A/s (5 from 506 patents)


5 patents:

1. 9643970 - Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitors

2. 8420667 - Isoquinolinone derivatives as NK3 antagonists

3. 8415373 - Isoquinolinone derivatives as NK3 antagonists

4. 8242134 - Isoquinolinone derivatives as NK3 antagonists

5. 8173639 - Isoquinolinone derivatives as NK3 antagonists

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…